ICAAC 45th

Drupal spam blocked by CleanTalk.
Title Content type
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Posaconazole (POS) vs Fluconazole (FLU) for Prophylaxis of Invasive Fungal Infections (IFIs) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients With Graft-Versus-Host Disease (GVHD): Results of a Multicenter Trial (click for details)
Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis (click for details)
Detection of Synergy by XTT-Enhanced Checkerboard Dilution Testing of Aspergillus: Correlation with Outcome in Patients with Invasive Aspergillosis Treated with Combination Voriconazole (VRC) and Caspofungin (CAS) Therapy (click for details)
Micafungin Enhances Neutrophil Oxidative Burst against Candida and Aspergillus (click for details)


Subscribe to ICAAC 45th